391 related articles for article (PubMed ID: 28485320)
1. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG
Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
Kollef MH; Ricard JD; Roux D; Francois B; Ischaki E; Rozgonyi Z; Boulain T; Ivanyi Z; János G; Garot D; Koura F; Zakynthinos E; Dimopoulos G; Torres A; Danker W; Montgomery AB
Chest; 2017 Jun; 151(6):1239-1246. PubMed ID: 27890714
[TBL] [Abstract][Full Text] [Related]
3. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
5. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
Gu WJ; Wang F; Tang L; Bakker J; Liu JC
Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
[TBL] [Abstract][Full Text] [Related]
8. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
[TBL] [Abstract][Full Text] [Related]
9. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
Niederman MS; Alder J; Bassetti M; Boateng F; Cao B; Corkery K; Dhand R; Kaye KS; Lawatscheck R; McLeroth P; Nicolau DP; Wang C; Wood GC; Wunderink RG; Chastre J
Lancet Infect Dis; 2020 Mar; 20(3):330-340. PubMed ID: 31866328
[TBL] [Abstract][Full Text] [Related]
10. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
[TBL] [Abstract][Full Text] [Related]
11. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit.
Palmer LB; Smaldone GC
Am J Respir Crit Care Med; 2014 May; 189(10):1225-33. PubMed ID: 24646034
[TBL] [Abstract][Full Text] [Related]
12. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
[TBL] [Abstract][Full Text] [Related]
14. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
Trials; 2015 Mar; 16():102. PubMed ID: 25872790
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
[TBL] [Abstract][Full Text] [Related]
20. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
Ghannam DE; Rodriguez GH; Raad II; Safdar A
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
